CAMP - Camp4 Therapeutics Corporation

Across the last three months, Camp4 Therapeutics Corporation's insiders have reduced their positions by a net 583,613 shares worth roughly $2.5M.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Andrew J. Schwab	2.03M	$7.79M	-
CEO	Josh Mandel-Brehm	285.0K	$1.09M	-
Dir	Richard A Young	186.4K	$713.9K	-
Other	Yuri Maricich	12.6K	$48.3K	-
CFO	Kelly Gold	10.0K	$38.3K	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 11, 2025	5am Partners VI, LLC	10% Owner	Buy	2,941,176	$1.53	$4,499,999.28	New	+105.8%	+52.9%
Sep 11, 2025	Amir Nashat49	Director, 10% Owner	Buy	1,307,189	$1.53	$1,999,999.17	-117.8%	+105.8%	+52.9%
Sep 11, 2025	Josh Mandel-Brehm	Chief Executive Officer	Buy	6,060	$1.65	$9,999.00	+2.2%	+105.8%	+52.9%
Sep 11, 2025	Yuri Maricich	Chief Medical Officer	Buy	6,060	$1.65	$9,999.00	New	+105.8%	+52.9%
Sep 11, 2025	Richard A Young	Director	Buy	15,151	$1.65	$24,999.15	+9.8%	+105.8%	+52.9%
Sep 11, 2025	Kelly Gold	Chief Financial Officer	Buy	6,060	$1.65	$9,999.00	+9.8%	+105.8%	+52.9%
Oct 15, 2024	Northpond Ventures II Gp, LLC	10% Owner	Buy	763,636	$11.00	$8,399,996.00	New	-63.3%	-68.0%
Oct 15, 2024	5am Partners VI, LLC	10% Owner	Buy	909,090	$11.00	$9,999,990.00	+53.0%	-63.3%	-68.0%
Oct 15, 2024	Enavate Sciences Gp, LLC	10% Owner	Buy	1,363,636	$11.00	$14,999,996.00	+56.3%	-63.3%	-68.0%
Oct 15, 2024	Ah Equity Partners Bio I, L.l.c.	10% Owner	Buy	727,272	$11.00	$7,999,992.00	-400.0%	-63.3%	-68.0%